BRCA1 and ovarian carcinoma: For instance, it is unknown to what extent findings would generalize to contexts where individuals can learn about genetic risk for severe diseases, such as genetic testing for high-penetrance familial risk such as BRCA1/2 genetic testing for hereditary breast and ovarian cancer.